Skip to main content
. 2019 Dec;8(6):920–928. doi: 10.21037/tlcr.2019.11.25

Figure S1.

Figure S1

Forest plot of subgroup analysis by baseline characteristics for PFS (A) and OS (B) following ICIs monotherapy. PFS, progression-free survival; OS, overall survival; ECOG, Eastern Cooperative Oncology Group; PS, performance status; irAE, immune-related adverse event.